SurVaxM: A New Hope for Glioblastoma Treatment With Dr. Ajay Abad

17 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In honor of Glioblastoma Awareness Day, Dr. Ajay Abad, Principal Investigator of the SURVIVE trial, discusses SurVaxM, a novel survivin-targeted vaccine offering hope for glioblastoma patients. Learn how this innovative immunotherapy mobilizes the immune system to target glioblastoma cells, with promising interim results showing potential to improve survival and quality of life.

Discover the challenges of glioblastoma treatment, the importance of clinical trial collaboration, and how SurVaxM is shaping the future of neuro-oncology.

#GlioblastomaAwarenessDay #SurVaxM #GlioblastomaTreatment #Immunotherapy #CancerResearch #NeuroOncology #OncologyInnovation #ClinicalTrials #PatientAdvocacy #CancerCare
Categoria
Oncology
Commenta per primo questo video.

Prossimo